search
Back to results

Normative Assessment of Adaptable Mouthguards. (ENORMPIBA)

Primary Purpose

Oral Manifestations

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Adaptable mouthguards
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Oral Manifestations focused on measuring Prototype, Adaptable mouthguards

Eligibility Criteria

18 Years - 35 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Subject aged 18 to 35,
  • Subject affiliated to a social security,
  • Subject who has signed the free and informed consent form.

Exclusion Criteria:

  • Subject with a pathology incompatible with the performance of the test, namely: Recent infarction,Threat syndrome, blood pressure resting> 200/120 mmHg, uncompensated cardiac insufficiency, atrioventricular block 3rd degree acquired, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac Tumor or Thrombus, Deep Vein Thrombosis, Pulmonary Embolism,
  • Subject under B-mimetic drug treatment,
  • Subject under safeguard of justice,
  • Subject participating in another search,
  • Subject during pregnancy.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    SIngle arm

    Arm Description

    The research is based on a population of men and women practicing a sport at risk of oral trauma.

    Outcomes

    Primary Outcome Measures

    Impact on ventilatory flow rate by minute
    Average of measured values in one minute, compared to maximum aerobic reference speed of the subject Modification of the ventilatory flow rate by min
    Impact on O2 consumption
    Average of measured values in one minute, compared to reference of the subject
    Impact on respiratory rate
    Average of measured values in one minute, compared to reference of the subject
    Impact on current volume
    Average of measured values in one minute, compared to reference of the subject
    Impact on CO2 production
    Average of measured values in one minute, compared to reference of the subject
    Impact on comfort according an analogical visual scale for 11 criteria
    According an analogical visual scale (from 0 to 10) for 11 criteria (retention, muco-gingival appearance, mouth opening height, volume of mouthguards, nausea, phonation, open mouth ventilation, tight jaw ventilation, salivation, masticatory muscles, temporomandibular joint)
    Impact on electromyographic recording
    The electromyographic activity will be amplified and filtered (bandwidth 10-1000 Hz). The signals will be digitized using a CED 1401 interface coupled to a microcomputer that is controlled by the "SPIKE2" software. The digitization frequency will be 2,000 Hz. The software "SPIKE2" will then calculate what is called "integrated electromyogram": the electromyographic signals will be rectified and filtered with a moving average having a period of 0,2 seconds.

    Secondary Outcome Measures

    Full Information

    First Posted
    August 13, 2019
    Last Updated
    August 13, 2019
    Sponsor
    University Hospital, Bordeaux
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04056559
    Brief Title
    Normative Assessment of Adaptable Mouthguards.
    Acronym
    ENORMPIBA
    Official Title
    Normative Assessment of Adaptable Mouthguards.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    September 9, 2011 (Actual)
    Primary Completion Date
    June 29, 2012 (Actual)
    Study Completion Date
    June 29, 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University Hospital, Bordeaux

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The aim of this study is to the validate adaptable mouthguards prototypes, patented by Bordeaux University and Bordeaux University Hospital.
    Detailed Description
    The current state of knowledge in the areas of mouthguards shows that type II (adaptable) models account for 90% of the mouthguards of the sporting population. But a majority of these devices do not appear to comply with the European Directive 89/686 / European Economic Community. A previous work consisted of the production of prototypes of mouthguards meeting the essential requirements of the directive. These prototypes were the subject of a patent filed by the Bordeaux University and the Bordeaux University Hospital. The aim of this study is to the validate the prototypes for a future launch on the market.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Oral Manifestations
    Keywords
    Prototype, Adaptable mouthguards

    7. Study Design

    Primary Purpose
    Device Feasibility
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Single
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    14 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    SIngle arm
    Arm Type
    Experimental
    Arm Description
    The research is based on a population of men and women practicing a sport at risk of oral trauma.
    Intervention Type
    Device
    Intervention Name(s)
    Adaptable mouthguards
    Intervention Description
    Validate a prototype of Adaptable Intra-Oral Protections patented by Bordeaux University and Bordeaux University Hospital according to 3 levels (ventilation, comfort, cervical muscle activity).
    Primary Outcome Measure Information:
    Title
    Impact on ventilatory flow rate by minute
    Description
    Average of measured values in one minute, compared to maximum aerobic reference speed of the subject Modification of the ventilatory flow rate by min
    Time Frame
    At Week 51
    Title
    Impact on O2 consumption
    Description
    Average of measured values in one minute, compared to reference of the subject
    Time Frame
    At Week 51
    Title
    Impact on respiratory rate
    Description
    Average of measured values in one minute, compared to reference of the subject
    Time Frame
    At Week 51
    Title
    Impact on current volume
    Description
    Average of measured values in one minute, compared to reference of the subject
    Time Frame
    At Week 51
    Title
    Impact on CO2 production
    Description
    Average of measured values in one minute, compared to reference of the subject
    Time Frame
    At Week 51
    Title
    Impact on comfort according an analogical visual scale for 11 criteria
    Description
    According an analogical visual scale (from 0 to 10) for 11 criteria (retention, muco-gingival appearance, mouth opening height, volume of mouthguards, nausea, phonation, open mouth ventilation, tight jaw ventilation, salivation, masticatory muscles, temporomandibular joint)
    Time Frame
    At Week 51
    Title
    Impact on electromyographic recording
    Description
    The electromyographic activity will be amplified and filtered (bandwidth 10-1000 Hz). The signals will be digitized using a CED 1401 interface coupled to a microcomputer that is controlled by the "SPIKE2" software. The digitization frequency will be 2,000 Hz. The software "SPIKE2" will then calculate what is called "integrated electromyogram": the electromyographic signals will be rectified and filtered with a moving average having a period of 0,2 seconds.
    Time Frame
    At Week 52

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    35 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Subject aged 18 to 35, Subject affiliated to a social security, Subject who has signed the free and informed consent form. Exclusion Criteria: Subject with a pathology incompatible with the performance of the test, namely: Recent infarction,Threat syndrome, blood pressure resting> 200/120 mmHg, uncompensated cardiac insufficiency, atrioventricular block 3rd degree acquired, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac Tumor or Thrombus, Deep Vein Thrombosis, Pulmonary Embolism, Subject under B-mimetic drug treatment, Subject under safeguard of justice, Subject participating in another search, Subject during pregnancy.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Philippe POISSON, Dr
    Organizational Affiliation
    University Hospital, Bordeaux
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Normative Assessment of Adaptable Mouthguards.

    We'll reach out to this number within 24 hrs